Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
01.08.24
/
50%
€5.25
Target price
01.08.25
€12.05
Performance (%)
-31.81%
End price
02.08.25
€3.58
Summary
This prediction ended on 02.08.25 with a price of €3.58. The BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals performed very badly with a performance of -31.81%. Cantor_Fitzgerald has a follow-up prediction for Vanda Pharmaceuticals where he still thinks Vanda Pharmaceuticals is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 21.552% | 21.552% | 49.364% |
| iShares Core DAX® | 0.869% | 2.751% | 22.676% |
| iShares Nasdaq 100 | -0.852% | -2.079% | 4.294% |
| iShares Nikkei 225® | 0.436% | -1.741% | 12.719% |
| iShares S&P 500 | -0.122% | -0.584% | 2.545% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
91.01%
09:04
09:04
